MTOR INHIBITOR-BASED IMMUNOSUPPRESSION IS ASSOCIATED WITH A HIGHER FREQUENCY OF IFN gamma-PRODUCING EBV-SPECIFIC CD4(+) T CELLS AS COMPARED TO MTOR INHIBITOR-FREE THERAPY IN KIDNEY TRANSPLANT PATIENTS
作者:
发布时间
2020-08-22
- 浏览0

Transplant international
140-140页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文